All News

Study shows measles can make other antibodies less effective.

An effective HIV vaccine has proven elusive, but a new type of vaccine may provide results.

Enhancing vaccination programs increase revenue and clientele base.

Laboratory analysis now includes ED dietary supplements. 

How chains are evolving-and how pharmacists will fit in.

Shown to reduce regular RBC transfusions in adults with beta thalassemia.

Why pancreatic cancer death rates are still so high.

A look at one of the most common forms of skin cancer.

Medication management and vaccination services among top services.

CVS to emphasize HealthHUB and chains test stand-alone pharmacies.

Fourth filgrastim biosimilar from Sandoz, expected ASAP.

Could lead to falsely high or low results, especially troponin assays.

Approved for ages 65 and older.

Practical tips to help keep patients safe.

Savings totaled $293 billion in 2018.

Abbreviated New Drug Applications, state laws, and more.

Analysts now speculating potential next moves.

First and currently only rifabutin-based H. pylori therapy approved.

Cancer type and chemotherapy are leading risk factors.

Vaccination significantly reduces the risk of the disease.

The states pharmacists should avoid.

Why research says understanding the overlap between Kaposi sarcoma-associated herpesvirus (KSHV) and human herpesvirus 8 (HHV8)-positive large B-cell lymphomas and associated diseases may lead to better outcomes.

New research indicates lower survival in patients with slower gait speed.

Site will offer CBD education and product marketing.

Walgreens and a California chain announced closures this week.

Delayed-release oral capsules for various forms of the disease.

Statin regimens may need tweaking to deliver optimal results. 

Fewer tracheobronchial branches may be a genetically-related risk factor.